case 2: frontline decisions in stage iv braf-mutant melanoma
Published 7 years ago • 296 plays • Length 8:13Download video MP4
Download video MP3
Similar videos
-
6:08
braf-mutant melanoma: frontline decisions
-
6:08
braf-mutant melanoma: frontline decisions
-
4:15
case 2: frontline treatment data in stage iv nsclc
-
6:39
questions about sequencing in braf-mutant melanoma
-
7:31
case 2: braf-mutated metastatic melanoma
-
8:00
case i: newly diagnosed braf–wild type advanced melanoma
-
7:01
dual-targeted therapy for braf-mutant melanoma
-
27:28
advances in therapy for braf-mutant melanoma
-
6:33
treatment of braf-mutant metastatic melanoma
-
9:49
melanoma: nuances of braf/mek combinations in the front line
-
10:08
emerging approaches for braf-mutant metastatic melanoma
-
1:17
treatment selection for stage iii braf-mutant melanoma
-
3:34
immunotherapy in braf wild-type melanoma
-
6:12
braf as a driver in melanoma
-
7:15
dual targeted or immunotherapy for braf-mutant melanoma
-
5:03
clinical trials for frontline therapy in melanoma
-
1:11
dr. flaherty on resistance in braf-mutant melanoma
-
5:31
treating braf-mutated metastatic melanoma
-
2:58
role of braf mutation in the treatment for melanoma